Back to search

Article

Increased tau expression in the <i>APOE4</i> blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery <i>in vitro</i>

2023-10-25

Abstract excerpt

Tau protein is a critical driver of neurodegeneration and an important drug target in Alzheimer’s disease (AD). Tau-specific immunotherapy has emerged as a promising treatment strategy for AD, however the therapeutic efficacy of anti-tau antibodies may be limited by their insufficient delivery across the blood-brain barrier (BBB). The apolipoprotein E4 allele ( APOE4 ) is the strongest genetic risk factor for spo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
efbe6227-c762-5c5b-a5f3-5ae463b64b1c
DOI
10.1101/2023.10.24.563706
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Increased tau expression in the <i>APOE4</i> blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery <i>in vitro</i>DOI 10.1101/2023.10.24.563706
Select a neighboring publication to make it the new centre.